Do Anti-VEGF Injections Increase the Risk of Stroke or Heart Attack?

Some have speculated that the anti-VEGF injections we give to macular degeneration patients may get into the bloodstream and have adverse vascular effects. According to a recently released retrospective study (appearing in the October 2010 issue of the Archives of Ophthalmology), using vascular endothelial growth factor (VEGF) blockers to treat neovascular age-related macular degeneration does not appear to increase the risk of (Read more...)

Full Story →